Kondroitin-szulfát (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kondroitin-szulfát" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

2^nd place

8^th place

4^th place

11^th place

1^st place

7,197^th place

low place

5^th place

22^nd place

6^th place

14^th place

archive.org

Five Things Physicians and Patients Should Question. Choosing Wisely: an initiative of the ABIM Foundation. American Academy of Orthopaedic Surgeons, 2013. február 1. [2015. április 8-i dátummal az eredetiből archiválva]. (Hozzáférés: 2013. május 19.)

(2009) „Effect of the counterion behavior on the frictional–compressive properties of chondroitin sulfate solutions”. Polymer 50 (7), 1805–1813. o. DOI:10.1016/j.polymer.2009.01.066.
(2015. január 28.) „Chondroitin for osteoarthritis.”. The Cochrane Database of Systematic Reviews 1, CD005614. o. DOI:10.1002/14651858.CD005614.pub2. PMID 25629804.
(2007) „Risk assessment for glucosamine and chondroitin sulfate”. Regulatory toxicology and pharmacology 47 (1), 78–83. o. DOI:10.1016/j.yrtph.2006.07.004. ISSN 0273-2300.
(2003) „an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)”. Ann Rheum Dis 62 (12), 1145–1155. o. DOI:10.1136/ard.2003.011742. PMID 14644851.
(2002) „Biosynthesis of chondroitin/dermatan sulfate”. IUBMB Life 54 (4), 177–86. o. DOI:10.1080/15216540214923. PMID 12512856.

Five Things Physicians and Patients Should Question. Choosing Wisely: an initiative of the ABIM Foundation. American Academy of Orthopaedic Surgeons, 2013. február 1. [2015. április 8-i dátummal az eredetiből archiválva]. (Hozzáférés: 2013. május 19.)

(2007) „Risk assessment for glucosamine and chondroitin sulfate”. Regulatory toxicology and pharmacology 47 (1), 78–83. o. DOI:10.1016/j.yrtph.2006.07.004. ISSN 0273-2300.